Clinical Trial Update: A 6-months Observational Study to Evaluate the Quality of Life of Patients Treated With Phytotherapy or Alpha-blockers for Benign Prostatic Hyperplasia

View source ↗

Summary

A completed 6-month observational study comparing phytotherapy and alpha-blockers for benign prostatic hyperplasia, assessing patients’ quality of life.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Alpha blockers
• Phytotherapy

Snippet

Sponsor: Pierre Fabre Medicament | Conditions: Benign Prostatic Hyperplasia | Status: COMPLETED